To further determine the differentiation trajectory of tumor-specific CD8+T cells, CD8+T cells in the peripheral blood were collected from mice treated with MWA + PBS and MWA + 2DG on day 35 (Supplementary Fig. 6a). The gene discussed is CD8A; the disease is neoplasm.